Navigation Links
Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
Date:12/16/2008

SAN MARINO, Calif., Dec. 16 /PRNewswire/ -- Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body. With profound demonstrations of clinical benefit and single-agent-efficacy, as well as overall safety, Epeius Biotech continues to lead the field of clinical gene medicine with the advent of pathotropic (or disease-seeking) targeting. These latest EU patents follow on the heels of a major clinical patent that was recently awarded in the USA for targeted gene delivery in vivo. Together these clinical patents provide additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company's leading anti-cancer agent Rexin-G(R) -- the first and so far only tumor-targeted gene delivery system that has been successfully validated in the clinic.

Based on recent breakthroughs in tumor-targeting and nanotechnology, a new generation of powerful biological anti-cancer agents that are exceedingly precise and highly selective for diseased tissues is currently in clinical development. Anti-cancer agents such as Rexin-G(R) can be delivered by simple intravenous infusion, yet are programmed to seek-out and accumulate selectively in primary and metastatic lesions that have spread throughout the body, delivering a tumor-killing gene while sparing normal cells and tissues. Representing the world's first targeted genetic medicine proven to be both safe and effective in the clinic, Rexin-G(R) is commercially available in the Philippines -- for use in all solid tumors that are refractory to standard chemotherapy -- and is currently in clinical trials in the USA for several types of cancer.

About Epeius Biotechnologies

Epei
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Targeting Metastatic Cancer From the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
2. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
3. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
4. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
5. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
8. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
9. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
10. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
11. Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... New York investment bank KTA Capital,s client Neu...$6.7 mil convertible note private placement with a...t was arranged by KTA Capital as Neuren,s exclusiv... New York (PRWEB) November 23, 2009 -- The ...LLC ("KTA Capital") has announced that i...
(Date:11/24/2009)...alth care employment grew by 29,000 jobs in Octob...sistent growth during the U.S. recession. However,..., and health systems are coming closer to having t...administrators. , (Vocus)...nued growing in October despite the shedding of jo...
(Date:11/24/2009)...wire/--BlueMarbleEnergyCorp.announcedtodaythatthec...wererecentlyawarded$2millionbyWashingtonState,sCom...publicpartnershiptoconstructthestate,sfirstspecial..."Thisinvestmentwillsignificantlyspeedthedevelopmen...ounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Weareg...
(Date:11/24/2009)...PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc.(N...uledtopresentatthePiperJaffray21stAnnualHealthCare...:30a.m.PacificTime)attheNewYorkPalaceHotelinNewYor...Officer,isscheduledtoprovideanoverviewofthecompany...ms. ,, Aliveaudiowebcastofthepresentationwillbe...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...euticals,Inc. (Nasdaq: AMLN ) today announced tha...oard of Directors effective immediately. "We are ...," said,Daniel M. Bradbury, President and CEO of A...ce as a highly innovative, strategic business lead...zations and delivering,optimum results will enhanc...
...iences,Holdings, Inc. (Nasdaq: ADLS ) today annou...man & Renshaw 9th Annual Healthcare Conference in ...aming audio. Advanced Life,Sciences, management wi...,business. (Logo: http://www.newscom.com/cgi-bin...tation will be delivered at 12:40 to 1:00PM in the...
...), a focus area of,SAFC(R) and part of the Sigma-A...ounced that it will be participating in a webcast,...and ST Microelectronics, to discuss,the subject of...ebcast will,address issues surrounding Flash (NAND...ALD as the semiconductor industry transitions to t...
Other Biology Technology:Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors 2Advanced Life Sciences to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast 2SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast 3
(Date:11/24/2009)... 24, 2009) -- The Wildlife Conservation Society (W...st remaining population of Siberian tigers has lik...of poaching and habitat loss. , WCS ... of what needs to be done to protect remaining pop... The report was released by the Siberian Tiger ...
(Date:11/23/2009)...rong evidence that the "synergistic" effect of ear...ollution and indoor endotoxin causes more harm to ...one. , Environmental health scientists at the ...have shown that children exposed to both high leve...in during early life are six times more likely to ...
(Date:11/23/2009)...rticipants gathered this week for the seventh annu...erence. This year,s topic, "Synthetic Biology," br...researchers to explore the engineering, scientific... of synthetic biology. , Bonnie L. Bassler, prof... and this year,s conference chair, challenged the ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 1Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 2Cynosure Names Paul Cardarelli Vice President of Business Development 57332 1Cynosure Names Paul Cardarelli Vice President of Business Development 57332 2Cynosure Names Paul Cardarelli Vice President of Business Development 57332 3Cynosure Names Paul Cardarelli Vice President of Business Development 57332 4Pesticides Linked to Parkinsons 57331 1Pesticides Linked to Parkinsons 57331 2
...In the study, the scientists screened known drugs ...conventional reprogramming genes, which can have d...ew way to generate stem cells from fibroblasts, a ...ssible from various tissues, including skin. , Th...ion (Volume 3, Issue 5) of the journal Cell Stem ...
...Heidelberg, 5 November 2008 - Today, the European ...e selection of 12 of Europe,s most talented young ...g Investigator Programme. , Now in its ninth year...and most promising European young researchers at a... group leaders receive a range of benefits designe...
... A Harvard-based study published October 29 in th...rs. Gottfried Schlaug and Ellen Winner has found t... least three years outperform children with no ins...scrimination and finger dexterity (skills honed by...ests measuring verbal ability and visual pattern c...
Other Biology News:Scripps research scientists identify compounds for stem-cell production from adult cells 2Scripps research scientists identify compounds for stem-cell production from adult cells 312 outstanding young scientists named as EMBO Young Investigators 2Research shows that time invested in practicing pays off for young musicians 2
Goat Anti-SCCRO (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
ATX Ponceau S red staining solution from Sigma-Aldrich
...utathione-S-transferases (GSTs) are a group of enz...biotics in mammals. The enzymes protect cells agai...e glutathione to electrophilic xenobiotics, and th...enic, and toxic effects of the compounds. GST acti...
Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
Biology Products: